Biopharma Updates: Sumitomo Surges on US Sales While INmune Bio Pushes Cancer Pipeline
Sumitomo Pharma is feeling pretty optimistic about its recently ended fiscal year. Riding a wave of strong North American sales,...
Sumitomo Pharma is feeling pretty optimistic about its recently ended fiscal year. Riding a wave of strong North American sales,...
Markets closed with a mix of optimism and trepidation on Friday as Apple delivered a stunning earnings beat for the...
In the fast-moving US biopharmaceutical sector, Carlsbad-based Palisade Bio, Inc. continues to draw attention with its specialized focus on gastrointestinal...